NOTICE OF ANNUAL GENERAL MEETING OF BIOHIT OYJ
BIOHIT OYJ STOCK EXCHANGE RELEASE 30 MARCH 2006
NOTICE OF ANNUAL GENERAL MEETING OF BIOHIT OYJ The shareholders of Biohit Oyj are invited to attend the Annual General Meeting (AGM) of Biohit Oyj to be held at Restaurant Pörssi on Thursday April 20th 2006 at 5:00 p.m., address: Fabianinkatu 14, 00100 Helsinki. Agenda The issues to be handled are those pertaining to the AGM as stipulated by Article 11 of the Companys Articles of Association. Board Structure and the Auditor Shareholders representing over 50% of the votes associated with the Group's shares have issued notification that they are going to propose to the AGM that the auditor remain the same, public accountancy company PricewaterhouseCoopers Oy, until the end of the subsequent AGM. Distribution of dividends and use of the share premium fund The Board of Directors will propose to the AGM that no dividends will be distributed for the financial year. The Board of Directors proposes to the General Meeting of Shareholders a decrease of the share premium fund. 612,688.29 euros will be used for the direct covering of a loss shown on an adopted balance sheet, and 12,229,626.52 euros will be transferred to a fund included in the companys non-restricted equity. The total amount of restricted shareholders equity after the decrease will be 2,199,396.59 euros and the total amount of the non-restricted shareholders equity will be 12,229,626.52 euros. The decrease will not have an effect on the total amount of the shareholders equity. No companys shares will be annulled or redeemed in connection with the decrease of the share premium fund. As far as the amount to be transferred to the fund included in the non-restricted equity is concerned, the decrease of the share premium fund is subject to the approval by the National Board of Patents and Registration of Finland, in accordance with Chapter 6 Section 5 in the Companies Act. By reducing the share premium fund, the company seeks to improve both its credibility on the stock exchange and its viability on the capital markets by improving the company's ability to pay dividends in the future. In addition, the purpose of the decrease is to prepare for the proposed reform of the Companies Act, pursuant to which the current concept of share premium fund will no longer exist. Documents The documents pertaining to the final accounts of the Company and the proposals by the Board of Directors to the AGM are available for review by shareholders as of March 31st 2006 at the Corporate Headquarters of Biohit, address Laippatie 1, 00880 Helsinki. Copies of the documents will be submitted to shareholders upon request. Right of Participation and Notification Shareholders who on April 10th 2006 have been listed on the shareholder register of the Company, maintained by the Finnish Central Securities Depository, have the right to participate in the Meeting. Shareholders who have not transferred their shares to the book- entry securities system are also entitled to participate in the AGM, provided that the shareholders have been registered in the corporate register of shareholders before April 10th 1995. In this case the shareholder is liable to present proof that the right of ownership of his/her shares has not been transferred to any book-entry securities account. Shareholders wishing to participate in the Annual General Meeting must notify the Company of their participation to the Corporate Headquarters no later than April 18th 2006 by 12:00 noon either in writing to: Biohit Oyj, Annual General Meeting, Laippatie 1, FI-00880, Helsinki, by e-mail to: yhtiokokous@biohit.com, by telefax to: +358-9-773 86 205 or by telephone to: Sanna Kurlin +358-9-773 861 (switchboard). Any powers of attorney must be submitted by mail before the closing of the registration period. Helsinki, March 30th 2006 Board of Directors of Biohit Oyj Additional information: Osmo Suovaniemi, M.D., Ph.D., Professor President & CEO Tel: +358-9-773 861 GSM: +358-40-745 5605 Email: osmo.suovaniemi@biohit.com Distribution: Helsinki Exchanges Financial Supervisory Authority Press http://www.biohit.com